Epigenetic modifications in AML and MDS

Leukemia Research

Volumn 34, Issue 2, 2010, Pages 139-140

  Mahmud, Mohammad ^a   Stebbing, Justin ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CHROMOSOME PROTEIN; DLK1 PROTEIN; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; MATERNALLY EXPRESSED GENE 3 PROTEIN; PROTEIN MLH1; SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME 14Q; CHROMOSOME 15; CLINICAL TRIAL; CPG ISLAND; DNA METHYLATION; EDITORIAL; EPIGENETICS; GENOME IMPRINTING; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REGULATORY SEQUENCE; SURVIVAL TIME; TRANSCRIPTION REGULATION;

DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES;

EID: 74849109347     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.07.019     Document Type: Editorial

References (14)

1. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Köhler G., Wijermans P., et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957-2964
2. Silverman L.R., Demakos E.P., Peterson B.L., Kornblith A.B., Holland J.C., Odchimar-Reissig R., et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20 (2002) 2429-2440
3. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukaemia and myelodysplastic syndromes. Leukemia Res; in press.
4. Chim C.S., Liang R., and Kwong Y.L. Hypermethylation of gene promoters in hematological neoplasia. Hematol Oncol 20 (2002) 167-176
5. Schuster-Gossler K., Bilinski P., Sado T., Ferguson-Smith A., and Gossler A. The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn 212 2 (1998) 214-228
6. Nogami M., Kohda A., Taguchi H., Nakao M., Ikemura T., and Okumura K. Relative locations of the centromere and imprinted SNRPN gene within chromosome 15 territories during the cell cycle in HL60 cells. J Cell Sci 113 (2000) 2157-2165
7. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
8. Baylin S.B. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 Suppl 1 (2005) S4-11
9. Galm O., Herman J.G., and Baylin S.B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev February (2005) [online]
10. Chuang J.C., and Jones P.A. Epigenetics and microRNAs. Pediatr Res 61 (2007) 24R-29R
11. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95 (1998) 6870-6875
12. http://nihroadmap.nih.gov/epigenomics/ (Accessed 25.06.2009).
13. Down T.A., Rakyan V.K., Turner D.J., Flicek P., Li H., Kulesha E., et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26 (2008) 779-785
14. McShane L.M., Altman D.G., Sauerbrei W., Taube S.E., Gion M., Clark G.M., et al. Reporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol 2 8 (2005) 416-422